ONL Therapeutics
Manufacturing · Michigan, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
524 S Main St Ste 110, Ann Arbor, Michig...Phone Number
(734) 412-8787Website
www.onltherapeutics.comRevenue
<$5 MillionIndustry
About ONL Therapeutics
ONL Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics to protect and enhance vision for patients suffering from various retinal diseases. Their lead candidate, xelafaslatide, is a first-in-class small peptide undergoing clinical trials for conditions like geographic atrophy associated with dry AMD. The company is pioneering a novel approach to prevent the death of key retinal cells through Fas-mediated signaling, addressing a significant medical need in vision preservation. ONL Therapeutics aims to provide new solutions for millions of individuals facing limited options for vision-related issues.Explore more
SIC Code 28,283NAICS Code 32,325Show moreONL Therapeutics Org Chart
Compare Similar Companies to ONL Therapeutics
Compare insights from companies similar to ONL Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ONL Therapeutics Tech Stack
A closer look at the technologies used by ONL Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ONL Therapeutics
Sign Up For FreeTo access detailed company insights
ONL Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics to protect and enhance vision for patients suffering from various retinal diseases. Their lead candidate, xelafaslatide, is a first-in-class small peptide undergoing clinical trials for conditions like geographic atrophy associated with dry... Read More
